Advertisement

Comparative Clinical Pathology

, Volume 28, Issue 4, pp 971–976 | Cite as

Detection of VanA type vancomycin resistance among MRSA isolates from an emergency hospital in Egypt

  • Mervat MashalyEmail author
  • Noha El-Mashad
  • Hend El-deeb
Original Article
  • 42 Downloads

Abstract

Resistance of methicillin-resistant Staphylococcus aureus (MRSA) strains to vancomycin is increasing and represents a major threat in the therapeutic fields. To assess susceptibility of S. aureus to vancomycin and determine the occurrence of VanA gene among MRSA isolates. Agar diffusion method using cefoxitin disc (30 μg) was used to identify MRSA among 100 isolates of S. aureus. Among MRSA, vancomycin resistance was determined by broth macrodilution and VanA gene was detected by PCR. Frequency of MRSA was 92%. Phenotypically, MRSA isolates were vancomycin-susceptible S. aureus (VSSA) (67.4%), vancomycin-intermediate S. aureus (VISA) (10.9%), and vancomycin-resistant S. aureus (VRSA) (21.7%). 17.4% of MRSA were VanA positive (75% were VRSA and 25% were VSSA). 82.6% of MRSA were VanA negative (76.3% were VSSA, 13.2% were VISA, and 10.3% were VRSA). Sixty percent of VRSA and 6.5% of VSSA were VanA gene positive but none of the detected VISA isolates was carrier of VanA gene. Percentage of MRSA, VISA, and VRSA detected in this study is alarming and highlights the need for implementation of strict infection control measures to prevent further dissemination of such resistant strains in our region.

Keywords

MRSA Vancomycin Broth macrodilution VanA gene 

Notes

Compliance with ethical standards

We obtained informed consents from all participants. An approval for this study with a code number of R/17.12.204 was received from our local ethics committee, Mansoura University ethical committee (IRB) and thus performed in accordance with the Declaration of Helsinki.

Conflict of interest

The authors declare that they have no competing interests.

References

  1. Abdel-Maksoud M, El-Shokry M, Ismail G et al (2016) Methicillin-resistant Staphylococcus aureus recovered from healthcare- and community-associated infections in Egypt. Int J Bacteriol 2016:1–5CrossRefGoogle Scholar
  2. Abu-Shady H, El-Essawy A, Salama M, El-Ayesh A (2012) Detection and molecular characterization of vancomycin resistant Staphylococcus aureus from clinical isolates. Afr J Biotechnol 11(99):16494–16503Google Scholar
  3. Alzolibani AA, Al Robaee AA, Al Shobaili HA, Bilal JA, Ahmad IM, Bin Saif G (2012) Documentation of vancomycin-resistant Staphylococcus aureus (VRSA) among children with atopic dermatitis in the Qassim region, Saudi Arabia. Acta Dermatovenerol Alp Pannonica Adriat 21(3):51–53Google Scholar
  4. Amr GE, Al Gammal S (2017) Emergence of vancomycin resistant Staphylococcus aureus isolated from patients in ICUs of Zagazig University Hospitals. Egyptian Journal of Medical Microbiology 26(2):53–59CrossRefGoogle Scholar
  5. Ashour HM, El-Sharif A (2007) Microbial spectrum and antibiotic susceptibility profile of gram-positive aerobic bacteria isolated from cancer patients. J Clin Oncol 25:5763–5769CrossRefGoogle Scholar
  6. Baddour MM, Abuelkheir MM, Fatani AJ (2006) Trends in antibiotic susceptibility patterns and epidemiology of MRSA isolates from several hospitals in Riyadh, Saudi Arabia. Annals of Clinical Microbiology and Antimicrobials 5:30CrossRefGoogle Scholar
  7. Banerjee T, Anupurba S (2012) Colonization with vancomycin-intermediate Staphylococcus aureus strains containing the vanA resistance gene in a tertiary-care center in North India. J Clin Microbiol 50(5):1730–1732CrossRefGoogle Scholar
  8. Barrow GI, Feltham RK, Cowan, Steel’s (2003) In: Cowan ST, Steel KJ (eds) Manual for the identification of medical bacteria. Cambridge University Press, CambridgeGoogle Scholar
  9. Clinical and Laboratory Standards Institute (2018) Performance standards for antimicrobial disk susceptibility tests; 28th edition, CLSI supplement M100. Wayne, PAGoogle Scholar
  10. Depardieu F, Perichon B, Courvalin P (2004) Detection of the Van alphabet and identification of Enterococci and Staphylococci at the species level by multiplex PCR. J Clin Microbiol 42(12):5857–5860CrossRefGoogle Scholar
  11. El-Baky RMA, Ahmed HR, Gad GFM (2014) Prevalence and conjugal transfer of vancomycin resistance among clinical isolates of Staphylococcus aureus. Adv Res 2(1):12–23CrossRefGoogle Scholar
  12. El-Banna T, Sonbol FI, Abd El-Aziz A, El-Ekhnawy E (2015) Characterization of vancomycin resistant Staphylococcus aureus in Tanta University Hospital. Int J Curr Microbiol App Sci 4(10):1–11Google Scholar
  13. Elliott P, Peakman TC (2008) The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol 37(2):234–244CrossRefGoogle Scholar
  14. Falagas ME, Karageorgopoulos DE, Leptidis J, Korbila IP (2013) MRSA in Africa: filling the global map of antimicrobial resistance. PLoS One 8(7):e68024CrossRefGoogle Scholar
  15. Gad YZ, Talaat NA (2012) Methecillin resistant staphylococcal aureus (MRSA) isolates from a hepatology intensive care unit in Egypt: a silent killer. Experimental & Clinical Hepatology 8:35–44Google Scholar
  16. Hasan R, Acharjee M, Noor R (2016) Prevalence of vancomycin resistant Staphylococcus aureus (VRSA) in methicillin resistant S. aureus (MRSA) strains isolated from burn wound infections. Tzu Chi Medical Journal 28(2):49–53CrossRefGoogle Scholar
  17. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC (1997) Methicillin resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40:135e6CrossRefGoogle Scholar
  18. Howden BP, Ward PB, Charles PG et al (2004) Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis 38:521e8CrossRefGoogle Scholar
  19. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, Rybak MJ, Talan DA, Chambers HF (2011) Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 52:1–38CrossRefGoogle Scholar
  20. Mahmood HA, Flayyih MT (2014) Detection of van A gene of vancomycin resistant Staphylococcus aureus by PCR technique. Int J 2(7):209–216Google Scholar
  21. Mahmoud M, Alkhaleefah F, Sherif DM (2013) Antimicrobial effects of epigallocatechingallate and epicatechins of green tea on planktonic and biofilm forms of staphylococcus aureus, including MRSA. Nature and Science 11(6):70–79Google Scholar
  22. Moses A, Uchenna U, Nworie O (2013) Epidemiology of vancomycin resistant staphyloccus aureus among clinical isolates in a tertiary hospital in Abakaliki, Nigeria. Am J Epidemiol Infect Dis 1(3):24–26Google Scholar
  23. Perichon B, Courvalin P (2009) VanA-type vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 53:4580–4587CrossRefGoogle Scholar
  24. Rehm SJ, Tice A (2010) Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin resistant S. aureus and vancomycin-resistant S. aureus. Clin Infect Dis 51(Suppl 2):S176–S182CrossRefGoogle Scholar
  25. Rybak MJ, Akins RL (2001) Emergence of methicillin-resistant Staphylococcus aureus with intermediate glycopeptide resistance. Drugs 61(1):1–7CrossRefGoogle Scholar
  26. Saadat S, Solhjoo K, Norooz-Nejad MJ, Kazemi A (2014) VanA and VanB positive vancomycin-resistant Staphylococcus aureus among clinical isolates in Shiraz, South of Iran. Oman Medical Journal 29(5):335–339CrossRefGoogle Scholar
  27. Shahrbanooie R (2005) Vancomycin resistance among clinical isolates of Staphylococcus aureus. Arch Iran Med 8(2):100–103Google Scholar
  28. Shindia AA, Ragab FA, Nasrat HM (2011) Emergence of high-level vancomycin resistant Staphylococcus aureus in the critical care patients Cairo University Hospitals. Aust J Basic Appl Sci 5:1281e90Google Scholar
  29. Sieradzki K, Tomasz A (2003) Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus. J Bacteriol 185:7103–7110CrossRefGoogle Scholar
  30. Singh AH, Aruna S (2014) A study on the prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus in a South Indian tertiary care hospital. Int J Curr Res Rev 6(23):14Google Scholar
  31. Song W, Lee KM, Kang HJ, Shin DH, Kim DK (2001) Microbiologic aspects of predominant bacteria isolated from the burn patients in Korea. Burns 27(2):136–139CrossRefGoogle Scholar
  32. Srinivasan A, Seifried S, Zhu L, Bitar W, Srivastava DK, Shenep JL, Bankowski MJ, Flynn PM, Hayden RT (2009) Short communication: methicillin-resistant Staphylococcus aureus infections in children and young adults infected with HIV. AIDS Res Hum Retrovir 25(12):1219–1224CrossRefGoogle Scholar
  33. Tenover FC, Biddle JW, Lancaster MV (2001) Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg Infect Dis 7:327–332CrossRefGoogle Scholar
  34. Thati V, Shivannavar CT, Gaddad SM (2011) Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad. Indian J Med Res 134(5):704–708CrossRefGoogle Scholar
  35. Wootton M, Howe R, Walsh T, Bennett P, MacGowan A (2002) In vitro activity of 21 antimicrobials against vancomycin-resistant Staphylococcus aureus (VRSA) and heteroVRSA (hVRSA). J Antimicrob Chemother 50(5):760–761CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Ltd., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Clinical Pathology, Faculty of MedicineMansoura UniversityMansouraEgypt
  2. 2.Laboratory MedicineGeneral Hospital, Ministry of HealthMansouraEgypt

Personalised recommendations